IN2013MU03583A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03583A
IN2013MU03583A IN3583MU2013A IN2013MU03583A IN 2013MU03583 A IN2013MU03583 A IN 2013MU03583A IN 3583MU2013 A IN3583MU2013 A IN 3583MU2013A IN 2013MU03583 A IN2013MU03583 A IN 2013MU03583A
Authority
IN
India
Prior art keywords
praziquantel
relates
pharmaceutically acceptable
acceptable excipients
pharmaceutical composition
Prior art date
Application number
Inventor
Geena Malhotra
Preeti Raut
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Priority to ZA2014/08333A priority Critical patent/ZA201408333B/en
Priority to IN3583MU2013 priority patent/IN2013MU03583A/en
Priority to PCT/GB2014/053366 priority patent/WO2015071668A1/en
Publication of IN2013MU03583A publication Critical patent/IN2013MU03583A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to pharmaceutical compositions comprising an anthelmintic agent. Specifically, the invention relates to a pharmaceutical composition comprising praziquantel or R- praziquantel in nanosized particles and one or more pharmaceutically acceptable excipients. The invention also relates to a process of preparing a pharmaceutical composition comprising praziquantel or R- praziquantel in nanosized particles and one or more pharmaceutically acceptable excipients; and its use in the treatment of anthelmintic infections.
IN3583MU2013 2013-11-14 2014-11-13 IN2013MU03583A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ZA2014/08333A ZA201408333B (en) 2013-11-14 2014-11-13 Pharmaceutical compositions
IN3583MU2013 IN2013MU03583A (en) 2013-11-14 2014-11-13
PCT/GB2014/053366 WO2015071668A1 (en) 2013-11-14 2014-11-13 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3583MU2013 IN2013MU03583A (en) 2013-11-14 2014-11-13

Publications (1)

Publication Number Publication Date
IN2013MU03583A true IN2013MU03583A (en) 2015-07-31

Family

ID=51947385

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3583MU2013 IN2013MU03583A (en) 2013-11-14 2014-11-13

Country Status (3)

Country Link
IN (1) IN2013MU03583A (en)
WO (1) WO2015071668A1 (en)
ZA (1) ZA201408333B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170078600A (en) 2014-09-12 2017-07-07 안티바이오틱스 에이피에스 Antibacterial use of halogenated salicylanilides
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
CN106420782B (en) * 2016-11-24 2019-01-18 成都乾坤动物药业股份有限公司 A kind of avermectin dispersible tablet and preparation method thereof
US11382865B2 (en) * 2016-12-09 2022-07-12 Bayer Animal Health Gmbh Pharmaceutical preparation and method for its manufacture
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation Drug compositions
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
RU2722272C1 (en) * 2019-04-30 2020-05-28 Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" Agent for treating and preventing nematodosis and cestodiasis in small domestic animals
US20220047506A1 (en) * 2020-08-12 2022-02-17 Villya LLC Praziquantel Formulations
EP4362945A1 (en) * 2021-07-01 2024-05-08 The University Of Western Australia Fish feed additives
CN115844843A (en) * 2022-12-27 2023-03-28 佛山市南海东方澳龙制药有限公司 Multi-unit dispersed insect-repellent sheet and method for producing the same
CN115869275A (en) * 2022-12-27 2023-03-31 佛山市南海东方澳龙制药有限公司 Insect expelling tablet for animals and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2373287B1 (en) * 2008-12-05 2018-05-30 Bayer Intellectual Property GmbH Extrudate of needle-like pharmaceutical actives
HU231017B1 (en) * 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Taste masked praziquantel compositions

Also Published As

Publication number Publication date
WO2015071668A1 (en) 2015-05-21
ZA201408333B (en) 2015-12-23

Similar Documents

Publication Publication Date Title
IN2013MU03583A (en)
PH12015501648B1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
PH12015502261A1 (en) Macrocyclic deaza-purinones for the treatment of viral infections
PH12015500983A1 (en) Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
PH12016501122A1 (en) Delayed release compositions of linaclotide
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
PH12015500724B1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
MX2016012574A (en) Substituted heteroaryl compounds and methods of use.
PH12014501991B1 (en) Phenicol antibacterials
MX2015010829A (en) Therapeutic compounds and uses thereof.
IN2014MN02236A (en)
IN2013MU00711A (en)
MX366829B (en) Itraconazole compositions and dosage forms, and methods of using the same.
PH12015502564A1 (en) Pyridone derivatives for the treatment of viral infections and further diseases
MX2015014657A (en) Novel phenicol antibacterial agents.
IN2013MU03428A (en)
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
UA81932U (en) Rotrin-denta, combined pharmaceutical gel composition for treating inflammations of oral mucosa